Target intelligence / Profile preview

Procollagen prolyl and lysyl hydroxylases (P4H/PLOD)

Target
P4H/PLOD
Molecular classification
Enzyme, 2-oxoglutarate-dependent dioxygenase, Oxidoreductase
01

Overview

Procollagen prolyl and lysyl hydroxylases are a group of iron- and 2-oxoglutarate-dependent dioxygenases essential for the post-translational modification of collagen [UniProt]. Prolyl 4-hydroxylase (P4H) catalyzes the formation of 4-hydroxyproline, which is critical for the thermal stability of the collagen triple helix, while lysyl hydroxylase (PLOD) produces hydroxylysine residues necessary for stable intermolecular cross-linking [StatPearls]. Dysregulation of these enzymes is a hallmark of various fibrotic diseases, where excessive collagen deposition leads to organ dysfunction, and in cancer, where they facilitate extracellular matrix remodeling and metastasis [PubMed]. Therapeutic strategies often focus on small-molecule inhibitors that compete with the 2-oxoglutarate cofactor or chelate the active-site iron to reduce collagen stability and accumulation [PubMed]. However, targeting these enzymes presents challenges regarding selectivity and the potential for systemic side effects, such as impaired wound healing or interference with other oxygen-sensing pathways like the HIF system [PubMed].

Other names
Collagen hydroxylasesProcollagen-proline 4-dioxygenaseProcollagen-lysine 5-dioxygenaseP4HPLODProlyl 4-hydroxylaseLysyl hydroxylase
02

Mechanism of action

Inhibition of procollagen hydroxylation by competing with the 2-oxoglutarate cofactor or chelating the active-site Fe2+ ion, which prevents the formation of stable collagen triple helices and cross-links [StatPearls, PubMed].

03

Biological functions

Collagen biosynthesisProtein hydroxylationExtracellular matrix organization
04

Disease associations

FibrosisCancerScurvyEhlers-Danlos syndromeOsteogenesis imperfecta
05

Safety considerations

Impaired wound healing [StatPearls]Connective tissue fragility [PubMed]Off-target inhibition of HIF-prolyl hydroxylases [PubMed]
06

Interacting drugs

Minoxidil

3 more in the full profile.

07

Biomarkers

Urinary hydroxyproline [StatPearls]Serum Procollagen type I N-terminal propeptide (PINP) [PubMed]Pyridinoline (PYD) [PubMed]

Beyond the preview

Go deeper on Procollagen prolyl and lysyl hydroxylases (P4H/PLOD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Procollagen prolyl and lysyl hydroxylases (P4H/PLOD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call